background

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

Published
August 3rd, 2015
Type
Staff Publication
Topic
Postpartum Hemorrhage
Authors
Winikoff, Beverly, Blum, Jennifer, Dabash, Rasha, Raghavan, Sheila, Durocher, Jill, Winikoff, B., Dabash, R., Durocher, J., Darwish, E., Ngoc, N.T.N.,León, W., Raghavan, S., Medhat, I., Chi, H.T.K., Barrera, G., Blum, J.
Downloads

This article describes the results of a clinical trial seeking to evaluate the use of misoprostol compared to standard oxytocics for treatment of postpartum hemorrhage in women who were not previously exposed to oxytocin during labor. The results demonstrate that misoprostol may be a suitable first-line treatment alternative for this indication particularly in settings in which use of oxytocin is not feasible.

Access the abstract.